VKTX – Viking Therapeutics, Inc.
Viking Therapeutics, Inc.VKTX
$37.74Name : Viking Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,265,991,936.00
EPSttm : -2.12
Viking Therapeutics, Inc.
$37.74
3.50%$1.37Float Short %
22.05
Margin Of Safety %
Put/Call OI Ratio
0.28
EPS Next Q Diff
-0.13
EPS Last/This Y
-1.6
EPS This/Next Y
-1.05
Price
39.1
Target Price
93.39
Analyst Recom
1.11
Performance Q
-7.08
Relative Volume
0.53
Beta
0.64
Ticker: VKTX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | VKTX | 33.75 | 0.24 | 0.20 | 250856 |
| 2025-10-21 | VKTX | 32.97 | 0.24 | 0.38 | 257118 |
| 2025-10-22 | VKTX | 31.42 | 0.25 | 0.43 | 259120 |
| 2025-10-23 | VKTX | 33.84 | 0.25 | 0.19 | 263918 |
| 2025-10-24 | VKTX | 34.5 | 0.25 | 0.23 | 275323 |
| 2025-10-27 | VKTX | 35.61 | 0.24 | 0.19 | 256804 |
| 2025-10-28 | VKTX | 34.93 | 0.24 | 0.22 | 262252 |
| 2025-10-29 | VKTX | 35.21 | 0.24 | 0.23 | 264622 |
| 2025-10-30 | VKTX | 38.21 | 0.24 | 0.26 | 267498 |
| 2025-10-31 | VKTX | 38 | 0.27 | 0.47 | 280029 |
| 2025-11-03 | VKTX | 36.08 | 0.27 | 0.24 | 274645 |
| 2025-11-04 | VKTX | 34.62 | 0.27 | 0.26 | 282491 |
| 2025-11-05 | VKTX | 36.47 | 0.27 | 0.25 | 287812 |
| 2025-11-06 | VKTX | 37.24 | 0.27 | 0.35 | 293101 |
| 2025-11-07 | VKTX | 36.76 | 0.27 | 0.24 | 297440 |
| 2025-11-10 | VKTX | 37.76 | 0.28 | 1.00 | 283912 |
| 2025-11-11 | VKTX | 40.61 | 0.28 | 0.27 | 290328 |
| 2025-11-12 | VKTX | 40.81 | 0.27 | 0.15 | 302964 |
| 2025-11-13 | VKTX | 39.01 | 0.27 | 0.29 | 308251 |
| 2025-11-14 | VKTX | 39.09 | 0.28 | 0.32 | 310674 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | VKTX | 33.75 | -206.6 | - | -2.34 |
| 2025-10-21 | VKTX | 32.96 | -206.6 | - | -2.34 |
| 2025-10-22 | VKTX | 31.42 | -206.6 | - | -2.34 |
| 2025-10-23 | VKTX | 33.93 | -206.6 | - | -2.34 |
| 2025-10-24 | VKTX | 34.40 | -158.6 | - | -2.53 |
| 2025-10-27 | VKTX | 35.93 | -158.6 | - | -2.53 |
| 2025-10-28 | VKTX | 34.93 | -178.2 | - | -2.61 |
| 2025-10-29 | VKTX | 35.20 | -178.2 | - | -2.61 |
| 2025-10-30 | VKTX | 38.17 | -178.2 | - | -2.61 |
| 2025-10-31 | VKTX | 38.08 | -178.2 | - | -2.61 |
| 2025-11-03 | VKTX | 36.03 | -177.3 | - | -2.61 |
| 2025-11-04 | VKTX | 34.63 | -177.3 | - | -2.61 |
| 2025-11-05 | VKTX | 36.47 | -177.3 | - | -2.61 |
| 2025-11-06 | VKTX | 37.25 | -177.3 | - | -2.61 |
| 2025-11-07 | VKTX | 36.77 | -177.3 | - | -2.61 |
| 2025-11-10 | VKTX | 37.77 | -177.3 | - | -2.61 |
| 2025-11-11 | VKTX | 40.60 | -177.3 | - | -2.61 |
| 2025-11-12 | VKTX | 40.76 | -177.3 | - | -2.61 |
| 2025-11-13 | VKTX | 39.00 | -177.3 | - | -2.61 |
| 2025-11-14 | VKTX | 39.10 | -177.3 | - | -2.61 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | VKTX | -1.05 | -1.61 | 25.25 |
| 2025-10-21 | VKTX | -1.05 | -1.61 | 25.25 |
| 2025-10-22 | VKTX | -1.05 | -1.61 | 25.25 |
| 2025-10-23 | VKTX | -1.05 | -1.61 | 25.25 |
| 2025-10-24 | VKTX | -1.05 | -1.61 | 25.25 |
| 2025-10-27 | VKTX | -1.04 | -1.95 | 23.33 |
| 2025-10-28 | VKTX | -1.04 | -1.95 | 23.33 |
| 2025-10-29 | VKTX | -4.18 | -1.95 | 23.21 |
| 2025-10-30 | VKTX | -4.18 | -1.95 | 23.21 |
| 2025-10-31 | VKTX | -4.18 | -1.95 | 23.21 |
| 2025-11-03 | VKTX | -4.12 | -1.88 | 23.22 |
| 2025-11-04 | VKTX | -4.12 | -1.88 | 23.22 |
| 2025-11-05 | VKTX | -4.12 | -1.88 | 23.22 |
| 2025-11-06 | VKTX | -4.12 | -1.88 | 23.22 |
| 2025-11-07 | VKTX | -4.12 | -1.88 | 23.22 |
| 2025-11-10 | VKTX | -4.12 | -4.37 | 23.22 |
| 2025-11-11 | VKTX | -4.12 | -4.37 | 23.22 |
| 2025-11-12 | VKTX | -4.12 | -4.37 | 22.05 |
| 2025-11-13 | VKTX | -4.12 | -4.37 | 22.05 |
| 2025-11-14 | VKTX | -4.12 | -4.37 | 22.05 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.81
Avg. EPS Est. Current Quarter
-0.89
Avg. EPS Est. Next Quarter
-0.94
Insider Transactions
-4.12
Institutional Transactions
-4.37
Beta
0.64
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
10
Growth Score
18
Sentiment Score
86
Actual DrawDown %
60.7
Max Drawdown 5-Year %
-78.9
Target Price
93.39
P/E
Forward P/E
PEG
P/S
P/B
6.17
P/Free Cash Flow
EPS
-2.12
Average EPS Est. Cur. Y
-2.61
EPS Next Y. (Est.)
-3.66
Target Price Estimates Raised
1
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.53
Return on Equity vs Sector %
-60.2
Return on Equity vs Industry %
-45.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.27
EBIT Estimation
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 50
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading